Globally, nine million people die each year from ischemic heart disease. Despite falling rates of heart disease, tackling it is still a stubborn challenge
The pathologies of heart conditions are complex and interwoven, but they often start with ischaemia.
Credit: Mohamed Ashour. Sources: 1. British Heart Foundation Heart & Circulatory Disease Statistics 2020 available at http://go.nature.com/2sjhs7q (2020); 2. National Heart, Lung and Blood Institute Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung and Blood Diseases (NIH, 2012); 3. Bottle, A. et al. Heart104, 600–605 (2018); 4. British Heart Foundation
On supporting science journalism
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
The incidence of many heart conditions in wealthy countries is declining. In the United Kingdom, for example, the rates of ischaemic heart disease (IHD), myocardial infarction and heart failure have decreased since 2005. The incidence of atrial fibrillation has increased, probably because of an ageing population.
If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.
I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.
If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.
